Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Taylor A. Black"'
Autor:
Bardia Yousefi, Michael J. LaRiviere, Eric A. Cohen, Thomas H. Buckingham, Stephanie S. Yee, Taylor A. Black, Austin L. Chien, Peter Noël, Wei-Ting Hwang, Sharyn I. Katz, Charu Aggarwal, Jeffrey C. Thompson, Erica L. Carpenter, Despina Kontos
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Among non-small cell lung cancer (NSCLC) patients with therapeutically targetable tumor mutations in epidermal growth factor receptor (EGFR), not all patients respond to targeted therapy. Combining circulating-tumor DNA (ctDNA), clinical var
Externí odkaz:
https://doaj.org/article/2bc9f76cb0c2446eb992e36476f5b7bf
Autor:
Moen Sen, Ryan M. Hausler, Keely Dulmage, Taylor A. Black, William Murphy, Charles H. Pletcher Jr, Ling Wang, Chang Chen, Stephanie S. Yee, Scott J. Bornheimer, Kara N. Maxwell, Ben Z. Stanger, Jonni S. Moore, Jeffrey C. Thompson, Erica L. Carpenter
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 7, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/0a106db67e8d471ba41b7ba01eec8319
Autor:
William J. Chapin, Jacob E. Till, Wei-Ting Hwang, Jennifer R. Eads, Thomas B. Karasic, Peter J. O'Dwyer, Charles J. Schneider, Ursina R. Teitelbaum, Janae Romeo, Taylor A. Black, Theresa E. Christensen, Colleen Redlinger Tabery, Amanda Anderson, Megan Slade, Michael LaRiviere, Stephanie S. Yee, Kim A. Reiss, Mark H. O'Hara, Erica L. Carpenter
Publikováno v:
JCO precision oncology. 6
PURPOSE Pancreatic ductal adenocarcinoma (PDAC) is associated with a poor prognosis. Multianalyte signatures, including liquid biopsy and traditional clinical variables, have shown promise for improving prognostication in other solid tumors but have
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Mutations Analyzed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08350c21e7795ce9c29cff93a63f6bbf
https://doi.org/10.1158/1078-0432.22475610
https://doi.org/10.1158/1078-0432.22475610
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Purpose:The role of plasma-based tumor mutation burden (pTMB) in predicting response to pembrolizumab-based first-line standard-of-care therapy for metastatic non–small cell lung cancer (mNSCLC) has not been explored.Experimental Design:A 500-gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dfee398bbbbfc5c85644bb8ae085830
https://doi.org/10.1158/1078-0432.c.6529125
https://doi.org/10.1158/1078-0432.c.6529125
Autor:
Erica L. Carpenter, David Issadore, Ben Z. Stanger, Bryson W. Katona, Charles M. Vollmer, Mark H. O'Hara, Andrew Adallah, Daniel Herman, Neha Bhagwat, Hanfei Shen, Andrew Lin, Kyle Tien, Taylor A. Black, Stephanie S. Yee, Theresa Christensen, Jacob E. Till, Jina Ko, Michael J. LaRiviere, Zijian Yang
Figure S1. Sample cohort of this study, which included 204 subjects in total. Workflow shows patient cohorts involved in each classification. * indicated 8 patients repeated in the discovery set and the training set. ** indicated 32 locally advanced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54dc6365a97a1024585caf83e8d7015e
https://doi.org/10.1158/1078-0432.22476264
https://doi.org/10.1158/1078-0432.22476264
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
pTMBand PD-L1 expression levels.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::907404d8eb997d205afbd17afc601de9
https://doi.org/10.1158/1078-0432.22475613.v1
https://doi.org/10.1158/1078-0432.22475613.v1
Autor:
Erica L. Carpenter, Roger B. Cohen, Corey J. Langer, Joshua M. Bauml, Jeffrey S. Wasser, Aditi P. Singh, Christine A. Ciunci, Abigail T. Berman, Elena Helman, Rebecca J. Nagy, Kimberly C. Banks, Benjamin A. Silva, Michael J. LaRiviere, Theresa E. Christensen, Stephanie S. Yee, Taylor A. Black, Wei-Ting Hwang, Katie J. Quinn, Austin L. Chien, Jeffrey C. Thompson, Charu Aggarwal
Development and validation of a plasma-based panel for mutation detection and assessment of TMB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab8830cf164cccd5b1739f881aa15920
https://doi.org/10.1158/1078-0432.22475619.v1
https://doi.org/10.1158/1078-0432.22475619.v1
Autor:
Taylor C. Black
Publikováno v:
International Journal of Performance Arts and Digital Media. :1-2
Autor:
Zhuoyang Wang, Charu Aggarwal, Stephanie S. Yee, Aseel Abdalla, Jacob Till, Taylor A. Black, Robyn T. Sussman, Jacquelyn J. Roth, Kojo S.J. Elenitoba-Johnson, Erica L. Carpenter, Wei-Ting Hwang, Hareena Sangha, Caren Gentile, Jeffrey C. Thompson, Mark H. O'Hara
Publikováno v:
J Mol Diagn
Circulating cell-free DNA (ccfDNA) is used increasingly as a cancer biomarker for prognostication, as a correlate for tumor volume, or as input for downstream molecular analysis. Determining optimal blood processing and ccfDNA quantification are cruc